… II study, we randomized COVID-19 patients requiring mechanical ventilation to receive
either therapeutic enoxaparin or the standard anticoagulant thromboprophylaxis. We evaluated …

… of prophylactic anticoagulation against intermediate-to-therapeutic anticoagulation among
unselected hospitalized COVID-19 patients … For critically ill COVID-19 patients, the benefits of …

… severe covid-19, and intermediate versus therapeutic thromboprophylaxis in moderate
covid-19. … with LMWH or direct acting oral anticoagulants for patients discharged after covid-19.8…

… prophylactic anticoagulation therapy is associated with reduced TCs in critically ill patients
with COVID-19, … trials comparing prophylactic and higher doses of anticoagulants are needed …

… Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19
and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, …

… dosing and timing for anticoagulation during the clinical course of COVID-19. Until clinical
trial … for the use of prophylactic anticoagulation as initial therapy for COVID-19 patients upon …

… that therapeutic anticoagulation in COVID-19 critical disease, … doses of prophylactic
anticoagulation in COVID-19 to confirm our … intermediate versus standard-dose anticoagulation …

… therapeutic anticoagulation improves outcomes in patients hospitalised with COVID-19 is …
the efficacy and safety of therapeutic versus prophylactic anticoagulation in this population. …

… , 26 were used and still remain a matter of debate, we also aimed to analyze different
prophylactic or therapeutic anticoagulation strategies introduced during hospitalization on patients' …

… and bleeding manifestations of COVID-19 patients, recorded an … a standard dose of
prophylactic anticoagulation. The same … patients receiving prophylactic doses of anticoagulants, …